These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10576046)

  • 1. Dosing and management guidelines for tacrolimus in renal transplant patients.
    van Hooff JP; Boots JM; van Duijnhoven EM; Christiaans MH
    Transplant Proc; 1999 Nov; 31(7A):54S-57S. PubMed ID: 10576046
    [No Abstract]   [Full Text] [Related]  

  • 2. Malabsorption of tacrolimus in kidney transplant recipients: a Japanese single center experience.
    Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Okuda H; Ito S; Shinmura H; Inui M; Harano M; Manu M; Koga S; Shiroyanagi Y; Goya N; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1718-20. PubMed ID: 11119906
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
    Ciancio G; Burke GW; Gaynor JJ; Carreno MR; Cirocco RE; Mathew JM; Mattiazzi A; Cordovilla T; Roth D; Kupin W; Rosen A; Esquenazi V; Tzakis AG; Miller J
    Transplantation; 2005 Aug; 80(4):457-65. PubMed ID: 16123718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression.
    Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S
    Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrolimus - Pharmacokinetic Considerations for Clinicians.
    Schutte-Nutgen K; Tholking G; Suwelack B; Reuter S
    Curr Drug Metab; 2018; 19(4):342-350. PubMed ID: 29298646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
    Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
    Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
    [No Abstract]   [Full Text] [Related]  

  • 7. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
    Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
    Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
    van Duijnhoven E; Christiaans M; Schäfer A; Undre N; van Hooff J
    Transplant Proc; 1998 Jun; 30(4):1266-7. PubMed ID: 9636514
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
    Undre NA; Schäfer A
    Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
    Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
    Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient.
    Butani L; Berg G; Makker SP
    Transplantation; 2002 Jan; 73(1):159-60. PubMed ID: 11793001
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
    Lye WC
    Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
    Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
    Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immunosuppression with tacrolimus in renal transplantation: a single center experience.
    Kim HC; Park SB; Han SY; Whang EA; Jeon DS; Kim HT; Cho WH; Park CH
    Transplant Proc; 2003 Feb; 35(1):217-8. PubMed ID: 12591370
    [No Abstract]   [Full Text] [Related]  

  • 18. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
    Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
    Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.
    Andrés A; Budde K; Clavien PA; Becker T; Kessler M; Pisarski P; Fornara P; Burmeister D; Hené RJ; Cassuto-Viguier E;
    Transplantation; 2009 Nov; 88(9):1101-8. PubMed ID: 19898206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in cyclosporine drug substitution: implications for patient management.
    Bartucci MR
    J Transpl Coord; 1999 Sep; 9(3):137-42; quiz 143-4. PubMed ID: 10703396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.